Skip to content

14 g vs. 16 g in Breast Biopsy

Comparison of Needle Gauge 14 vs. Gauge 16 in Breast Biopsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03212040
Enrollment
186
Registered
2017-07-11
Start date
2011-12-05
Completion date
2018-06-07
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Biopsy

Brief summary

Comparison of biopsy needles with a different diameter, i.e. 14 vs 16 gauge, used for breast biopsies

Interventions

DIAGNOSTIC_TESTneedle biopsy

breast biopsy using different needle gauges

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Comparison of 14 vs 16 gauge needles

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Minimum age of 18 years * Informed consent available * Palpable and non-palpable breast findings * Tumor size 5-20 mm * Findings of sonographic BI-RADS® classification 2-5. * Guideline-oriented indication for bioptic clarification

Exclusion criteria

* No reliable sonographic demarcation of the finding * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy1 year* Diagnostic aggreement (representativity) with definitive histology of core needle specimen and of surgical specimen * Additive diagnostic aggreement (representativity) with definitive histology of core needle specimen and with histology of surgical specimen, with 1 to 5 passes of core needle biopsy * Additive diagnostic accuracy to achieve a high (\>=99%) diagnostic yield, with 1-5 passes of core needle biopsy
Diagnostic quality1 year* Diagnostic quality of specimen to achieve an accurate histological diagnosis * Diagnostic quality of specimen to achieve an accurate histological diagnosis, with 1 to 5 passes of core needle biopsy * Additive diagnostic quality to achieve a high (\>=99%) diagnostic yield, with 1-5 passes of core needle biopsy

Secondary

MeasureTime frameDescription
Pain related to the biopsy procedure1 yearSubjective pain perception measured visual analog scale
Duration time of the biopsy procedure1 yearDuration time of the biopsy procedure

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026